151 related articles for article (PubMed ID: 21689775)
21. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
22. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
[TBL] [Abstract][Full Text] [Related]
23. Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD.
Terzano C; Petroianni A; Conti V; Ceccarelli D; Graziani E; Sanduzzi A; D'Avelli S
Respir Med; 2008 Dec; 102(12):1701-7. PubMed ID: 18760583
[TBL] [Abstract][Full Text] [Related]
24. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
25. Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjects.
Singh D; Tal-Singer R; Faiferman I; Lasenby S; Henderson A; Wessels D; Goosen A; Dallow N; Vessey R; Goldman M
Br J Clin Pharmacol; 2006 Apr; 61(4):398-404. PubMed ID: 16542200
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
Kanehara M; Yokoyama A; Tomoda Y; Shiota N; Iwamoto H; Ishikawa N; Taooka Y; Haruta Y; Hattori N; Kohno N
Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
[TBL] [Abstract][Full Text] [Related]
27. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
[TBL] [Abstract][Full Text] [Related]
28. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
29. Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes.
Kolsum U; Borrill Z; Roy K; Starkey C; Vestbo J; Houghton C; Singh D
Respir Med; 2009 Jan; 103(1):136-43. PubMed ID: 18760576
[TBL] [Abstract][Full Text] [Related]
30. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.
Inui N; Matsushima S; Kato S; Yasui H; Kono M; Fujisawa T; Enomoto N; Nakamura Y; Toyoshima M; Suda T
Int J Chron Obstruct Pulmon Dis; 2015; 10():1139-46. PubMed ID: 26124653
[TBL] [Abstract][Full Text] [Related]
31. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ
Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868
[TBL] [Abstract][Full Text] [Related]
32. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
Buhl R; Dunn LJ; Disdier C; Lassen C; Amos C; Henley M; Kramer B;
Eur Respir J; 2011 Oct; 38(4):797-803. PubMed ID: 21622587
[TBL] [Abstract][Full Text] [Related]
33. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
34. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
Tashkin DP; Donohue JF; Mahler DA; Huang H; Goodwin E; Schaefer K; Hanrahan JP; Andrews WT
Respir Med; 2009 Apr; 103(4):516-24. PubMed ID: 19208459
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
Tashkin D; Kesten S
Chest; 2003 May; 123(5):1441-9. PubMed ID: 12740259
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Fukuchi Y; Nagai A; Seyama K; Nishimura M; Hirata K; Kubo K; Ichinose M; Aizawa H;
Treat Respir Med; 2005; 4(6):447-55. PubMed ID: 16336029
[TBL] [Abstract][Full Text] [Related]
37. Low frequency oscillometry parameters in COPD patients are less variable during inspiration than during expiration.
Kubota M; Shirai G; Nakamori T; Kokubo K; Masuda N; Kobayashi H
Respir Physiol Neurobiol; 2009 Apr; 166(2):73-9. PubMed ID: 19429522
[TBL] [Abstract][Full Text] [Related]
38. Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD.
Canto ND; Ribeiro JP; Neder JA; Chiappa GR
Respir Med; 2012 Oct; 106(10):1404-12. PubMed ID: 22748747
[TBL] [Abstract][Full Text] [Related]
39. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
Ichinose M; Fujimoto T; Fukuchi Y
Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
Minami S; Kawayama T; Ichiki M; Nishiyama M; Sueyasu Y; Gohara R; Kinoshita M; Koga H; Iwanaga T; Aizawa H
Intern Med; 2008; 47(6):503-9. PubMed ID: 18344636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
